Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessStocks

Claris Lifesciences rises 3% as RBI allows FPIs to raise stake to 49%

Foreign Portfolios Investors investment limit under Portfolio Investment Scheme in Claris Lifesciences has increased from 24 percent to 49 percent of its paid up capital.

October 18, 2017 / 12:44 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Claris Lifesciences share price gained 2.6 percent intraday Wednesday after the Reserve Bank of India has allowed foreign investors to raise their stake in the company to 49 percent.

"Foreign Institutional Investors (FIIs)/Foreign Portfolios Investors (FPIs) investment limit under Portfolio Investment Scheme in Claris Lifesciences has increased from 24 percent to 49 percent of its paid up capital," the RBI said in a notification.

Further, the RBI said the investment limit by NRIs has gone up to 24 percent from the existing 10 percent.

"Owing to the increase in the investment limit, it is notified that the aggregate shareholding by FIIs/FPIs in Claris Lifesciences has gone below the prescribed FIIs/FPIs investment limit for the company," it said.

Hence, the restrictions placed on the purchase of shares of the above company by FIIs/FPIs are withdrawn with immediate effect, the RBI added.

FIIs, NRIs and PIOs (Persons of Indian Origins) can invest in primary and secondary capital markets in India through PIS.

The RBI monitors ceilings on FII/NRI/PIO investments in Indian companies on a daily basis. It has fixed the cut-off points two percentage points lower than the actual ceiling.

At 12:06 hours IST, the stock price was quoting at Rs 352.00, up Rs 1.25, or 0.36 percent on the BSE.

first published: Oct 18, 2017 12:44 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347